Navigation Links
GlaxoSmithKline Obtains Exclusive U.S. OTC Marketing Rights to MEVACOR(R) (lovastatin) from Merck & Co., Inc.
Date:11/26/2007

To 100 To 130

(10-year risk >20%) (100-129: drug optional)

++

2+ Risk factors <130 Greater Than or Equal 10-year risk 10-20%:

(10 year risk Less To 130 Greater Than or Equal

Than or Equal To 20%) To 130

10-year risk <10%:

Greater Than or Equal

To 160

0-1 Risk factor+++ <160 Greater Than or Equal Greater Than or Equal

To 160 To 190

(160-189: LDL-lowering

drug optional)

+ CHD, coronary heart disease

++ Some authorities recommend use of LDL-lowering drugs in this category if an LDL-C level of <100 mg/dL cannot be achieved by therapeutic lifestyle changes. Others prefer use of drugs that primarily modify triglycerides and HDL-C, e.g., nicotinic acid or fibrate. Clinical judgment also may call for deferring drug therapy in this subcategory.

+++ Almost all people with 0-1 risk factor have a 10-year risk <10%; thus, 10-year risk assessment in people with 0-1 risk factor is not necessary.

After the LDL-C goal has been achieved, if the TG is still Greater Than or Equal To 200 mg/dL, non-HDL-C (total-C minus HDL-C) becomes a secondary target of therapy. Non-HDL-C goals are set 30 mg/dL higher than LDL-C goals for each risk category.

At the time of hospitalization for an acute coronary event, consideration can be given to initiating drug therapy at discharge if the LDL-C is Greater Than or Equal To 130 mg/dL (see NCEP Guidelines above).

Since the goa
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine news :

1. GlaxoSmithKline Responds to JAMA Articles
2. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
3. Congressional Black Caucus Foundation and GlaxoSmithKline Announce Supplier Business Initiative Study Results
4. AUDIO from Medialink and GlaxoSmithKline: A New Nasal Spray for Allergy Relief
5. Mylan Announces Settlement of Paroxetine Hydrochloride Extended-Release Tablets with GlaxoSmithKline
6. GlaxoSmithKline Aids California Fire Relief Efforts
7. Genmab and GlaxoSmithKline Initiate Ofatumumab Rheumatoid Arthritis Phase III Program
8. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
9. Southwest Ambulance Awarded Exclusive, 3-Year Contract Extension in Peoria, Arizona
10. Crdentias VP of Marketing, Christina Hogan, Provides Exclusive Interview on Marketing Strategy
11. Pearson VUE Signs Exclusive Contract with Educational Resources, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... (PRWEB) March 05, 2015 Risperdal ... in a Pennsylvania mass tort litigation currently underway ... a jury has begun hearing testimony in the ... atypical antipsychotic medication can cause gynecomastia, or male ... in question was filed on behalf of a ...
(Date:3/5/2015)... 2015 HomeCEUConnection.com is proud ... extra savings on their nutrition CEUs. To ... and nutrition, HomeCEUConnection.com is offering 10% off ... code, NUTRITION2015 . , High Quality ... HomeCEUConnection.com provides high-quality continuing education courses for ...
(Date:3/5/2015)... In honor of National Drug Facts ... drug and alcohol abuse in schools and communities across ... with information on some of the dangers and statistics ... National Institute on Drug Abuse, this annual promotion of ... the illusions that teens and young adults get from ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 Califia ... today announced at Natural Products Expo West that its ... now 100 percent soy and dairy free. Califia Farms ... serve bottle and are packed with six grams of ... that includes fiber, B vitamins and magnesium. , Protein ...
(Date:3/5/2015)... Supply & Demand Chain Executive Magazine has ... Know” in the supply chain industry, and we are ... team were included on this year’s list! Russ King ... due to their hard work, their commitment to excellence, ... resolving client needs and challenges. , Russ ...
Breaking Medicine News(10 mins):Health News:Risperdal Lawsuits Move Forward in Pennsylvania, as Bernstein Liebhard LLP Comments on Start of Second Gynecomastia Trial 2Health News:Risperdal Lawsuits Move Forward in Pennsylvania, as Bernstein Liebhard LLP Comments on Start of Second Gynecomastia Trial 3Health News:HomeCEUConnection.com Offers Nutrition CEUs this March to Celebrate Nutrition Month 2Health News:A Forever Recovery Issues New Tips for Sobriety for National Drug Facts Week 2Health News:Califia Farms Vegan Protein and New Single Serve Almondmilks to Hit Supermarket Shelves this Month 2Health News:Califia Farms Vegan Protein and New Single Serve Almondmilks to Hit Supermarket Shelves this Month 3Health News:MEBC Leaders Awarded Supply Demand Chain Executive Pros to Know Title For 2015 2
... in the United States, affecting 27 million Americans. In ... OA among the nursing community, Hospital for Special Surgery ... Association of Orthopaedic Nurses will present a groundbreaking two-day ... on Thursday, July 14, and Friday, July 15. ...
... , TUESDAY, July 12 (HealthDay News) -- ... infants with cystic fibrosis does not improve their long-term ... children with cystic fibrosis are associated with increased risk ... use of bronchoalveolar lavage (BAL), an alternative diagnostic procedure ...
... Severity of spinal cord injury in adults is ... State University researchers have found. In a study ... Journal of Spinal Cord Medicine, Cathy Lysack, Ph.D., deputy ... Wayne State researcher Katerina Machacova, Ph.D., and Stewart Neufeld, ...
... By Ellin Holohan HealthDay Reporter , TUESDAY, July ... diagnose Alzheimer,s disease may have just taken a small step ... could allow wider use of the imaging technique that, to ... funded by the manufacturers of the tracers. PET scans, ...
... new study published in the American Journal of ... (betaPV) infection and cutaneous squamous cell carcinoma (SCC) in ... cancer and SCC in the anogenital area and also ... neck cancer. SCC skin cancer is increasing in incidence ...
... Mann HealthDay Reporter , TUESDAY, July 12 ... of bladder cancer don,t get the recommended treatments, which ... their disease, researchers say. New research published online ... one of 4,545 people with high-grade, noninvasive bladder cancer ...
Cached Medicine News:Health News:State of the Science in the Prevention and Management of Osteoarthritis-A Conference for Nurses 2Health News:Severity of spinal cord injury has no impact on how adults rate their health, WSU research finds 2Health News:Alzheimer's Brain Protein Scanning Moves Forward 2Health News:Alzheimer's Brain Protein Scanning Moves Forward 3Health News:Bladder Cancer Patients Not Getting Recommended Care: Study 2Health News:Bladder Cancer Patients Not Getting Recommended Care: Study 3
(Date:3/5/2015)... N.J. , March 5, 2015  Medical ... which specializes in high complexity, state-of-the-art, automated DNA-based ... new Human Papillomavirus (HPV) testing which utilizes cutting ... Each year, approximately 12,000 women are ... United States . Genital Human Papillomaviruses (HPV) ...
(Date:3/5/2015)... N.Y. , March 5, 2015  AMRI (NASDAQ: ... Pettersson , fills the newly created position of VP ... Christopher Conway , Senior Vice President of Global Sales ... Pettersson will lead the international sales team in an ... share in targeted market segments. Mr. Pettersson will drive ...
(Date:3/5/2015)... 2015 LUNGevity Foundation, the nation,s leading ... Administration,s (FDA) approval of Bristol Myers Squibb,s new ... treatments add another critical new treatment option to ... a patient,s own immune system to fight cancerous ... for patients with squamous cell lung cancer, a ...
Breaking Medicine Technology:Medical Diagnostic Laboratories, L.L.C., the Institute for Biomarker Research Announces New HPV Tests 2Medical Diagnostic Laboratories, L.L.C., the Institute for Biomarker Research Announces New HPV Tests 3AMRI Hires VP of International Sales 2LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 2LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 3
Curved tying spring forceps made of titanium, delicate smooth jaws, length 10 mm, TCI jaws with round handle, diam. 8 mm and overall length 115 mm....
Tying forceps with flat serrated handle 88 mm, made of titanium, angled 30 with 4.5 mm tying platform....
Titanium hoskin suture tying forceps, 4.75"....
Straight Jaywant micro tying forceps....
Medicine Products: